•Pediatric inflammatory bowel diseases in patients with genetic syndromes: A case-control multicentre SIGENP study
•Glutaredoxin 1 facilitates colitis recovery by controlling glutathionylation and activity of STAT6 in M2 macrophages
•Pediatric intestinal enteroids derived from very early onset inflammatory bowel disease reveal differences in growth, morphology, and barrier function
•Immune-mediated comorbidities in multiple sclerosis: a scoping review
•The hidden burden of sarcopenia in inflammatory bowel disease: a strong predictor of complications